Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Kyverna Therapeutics, Inc. (KYTX) had Operating Cash Flow per Share of $-1.04 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-44.63M |
|
-- |
|
-- |
|
$47.41M |
|
$-47.41M |
|
$2.77M |
|
$-44.63M |
|
$-44.63M |
|
$-44.63M |
|
$-44.63M |
|
$-44.63M |
|
$-44.63M |
|
$-47.41M |
|
$-46.91M |
|
43.22M |
|
43.22M |
|
$-1.03 |
|
$-1.03 |
|
| Balance Sheet Financials | |
$247.65M |
|
$2.44M |
|
$13.00M |
|
$260.65M |
|
$33.29M |
|
$0.07M |
|
$3.35M |
|
$36.65M |
|
$224.01M |
|
$224.01M |
|
$224.01M |
|
43.22M |
|
| Cash Flow Statement Financials | |
$-44.91M |
|
$5.58M |
|
$-0.41M |
|
$97.17M |
|
$57.42M |
|
$-39.75M |
|
$2.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.44 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-44.91M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.93% |
|
-19.93% |
|
-17.12% |
|
-19.92% |
|
$5.18 |
|
$-1.04 |
|
|
Operating Cash Flow per Share |
$-1.04 |